Treatment of vestibular vertigo with Vertidisan - Longitudinal trial

Phase 4

• Conditions: H81; Disorders of vestibular function

• Registration Number: DRKS00030712
• Lead Sponsor: Digitineers GmbH&CoKG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-06
• Study Completion: 2024-03-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

Vestibular vertigo

Exclusion Criteria

Severe bone disease
Severe internal disease
Severe neurological disease
Central vertigo
Severe visual disorder
No German language

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VSS-sf-VER Score; Questionaire at T0 and after 12, 24 and 48 weeks

Secondary Outcome Measures

Name	Time	Method
QoL SF36, DHI, CGI-I, CGI-S, Stress thermometer, VSS-sf-AA